Identification of an oral microbiota signature associated with an impaired orosensory perception of lipids in insulin-resistant patients
Sign Up to like & getrecommendations! Published in 2020 at "Acta Diabetologica"
DOI: 10.1007/s00592-020-01567-9
Abstract: Type 2 diabetes leads to multiple sensory dysfunctions affecting notably the gustatory sensitivity. Although this sensory defect, by impacting food choices, might lead to unhealthy eating behavior, underlying mechanisms remains poorly studied. We have recently… read more here.
Keywords: microbiota; perception lipids; orosensory perception; perception ... See more keywords
T164. NETWORK CONNECTIVITY SUPPORTING REWARD LEARNING DIFFERENTIALLY DISRUPTED IN TREATMENT RESISTANT SCHIZOPHRENIA
Sign Up to like & getrecommendations! Published in 2020 at "Schizophrenia Bulletin"
DOI: 10.1093/schbul/sbaa029.724
Abstract: Abstract Background It is estimated that one third of patients with schizophrenia fail to adequately respond to antipsychotic medication, termed ‘treatment-resistance’. This occurs despite adequate blockade of D2 receptors in the brain. The parsimonious options… read more here.
Keywords: network; treatment; connectivity; reward learning ... See more keywords
The clinical efficacy and limitations of dutasteride-regulated abiraterone metabolism in abiraterone-resistant patients: a prospective single-arm clinical trial in Chinese patients
Sign Up to like & getrecommendations! Published in 2022 at "Translational Andrology and Urology"
DOI: 10.21037/tau-22-507
Abstract: Background The steroidal metabolism of abiraterone has been proposed to be involved in abiraterone resistance and limited approaches are available for abiraterone-resistant patients. Dutasteride regulates abiraterone metabolism in patients and might enhance the clinical efficacy… read more here.
Keywords: metabolism; resistant patients; abiraterone; abiraterone resistant ... See more keywords
Augmentation strategies for clozapine-resistant patients with schizophrenia.
Sign Up to like & getrecommendations! Published in 2020 at "Current pharmaceutical design"
DOI: 10.2174/1381612826666200110102254
Abstract: BACKGROUND Clozapine has been used in treatment-resistant patients with schizophrenia. However, only 40% of patients with treatment-resistant schizophrenia have response to clozapine. Many augmentation strategies have been proposed to treat those clozapine-resistant patients, but the… read more here.
Keywords: patients schizophrenia; clozapine resistant; augmentation strategies; resistant patients ... See more keywords
“DOST” Model to Link and Support Drug Resistant TB Patients From Private Sector: An Experience From Delhi, India
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Public Health"
DOI: 10.3389/fpubh.2022.835055
Abstract: Background The National TB Elimination Programme (NTEP) has quite successfully involved private sector for referral of presumptive drug resistant TB (DR-TB) patients for molecular testing and referral for DR-TB management. There was a challenge as… read more here.
Keywords: resistant patients; sector; model; drug resistant ... See more keywords
Multiple drug-resistant HBV mutation may contribute to poor response of adefovir + entecavir in entecavir-resistant patients.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of infection in developing countries"
DOI: 10.3855/jidc.12643
Abstract: INTRODUCTION Adefovir plus entecavir (ADV+ETV) rescue therapy in ETV-resistant patients with chronic hepatitis B virus (HBV) infection is suboptimal in some patients. This study aims to elucidate the evolutionary characteristics of drug-resistant HBV mutants and… read more here.
Keywords: entecavir; etv resistant; hbv; drug ... See more keywords